spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Kallik’s Release 6 sets new benchmarks for speed, accuracy and efficiency

Kallik


• Lightning-fast search results to identify thousands of labels impacted by change across print and online formats

• Prove labelling compliance in seconds whether printed or published electronically

• Globally manage larger and more diverse product portfolios through a single cloud-based solution
Tamworth, UK – 15 June 2019 – Global provider of labelling and artwork management solutions, Kallik, is launching an update to its AMS360 solution – its Release 6, transforming the experience of the business user, whilst defining new benchmarks for speed, accuracy, and efficiency of global labelling and artwork processes.

More complex and competitive marketplaces, weaker margins, and increasing enforcement of regulations, place ever-increasing challenges on managing larger and more diverse product portfolios across ever-developing channels.

Being able to prove compliance is paramount within labelling. With Release 6, not only are diverse product portfolios centralised in one single cloud-based platform, achieving transparency across all channels, but compliance can be demonstrated within seconds.

For the first time, global organisations are able to derive printed and electronic labelling from one integrated solution. Release 6 is driven by the latest web technologies, maximising user experience whilst providing greater data oversight and transparency.

A brand-new user interface simplifies content collation whilst providing greater visibility of assigned tasks and progress. Responding to demands for more tailored products and local market regulations, the solution delivers greater volumes of components that can be assigned to a labelling project without any degradation in performance.

Ashley Goldie, Managing Director of Kallik, said: “Global organisations now have the ability to source an integrated solution which provides complete oversight and data transparency across both printed and electronic labelling. Not only is a faster user experience being offered with this update, it also brings new productivity gains to activities such as data capture, content collation and impact analysis.

“Release 6 of AMS360 redefines the benchmarks for accuracy and efficiency of global labelling. With organisations seeking to derive greater efficiencies whilst continuing to satisfy increasingly stringent legislation and regulation, we truly believe it is a very needed and necessary solution.”

Release 6 adheres to these principles by eliminating costly and inefficient processes, reducing risk of non-compliance, enabling optimal use of labelling resources across the entire global organisation.

To find out more information about Kallik’s Release 6, and schedule a demo, visit here.

For more information about Kallik, please visit http://www.kallik.com

About Kallik

Kallik is a global provider of labelling and artwork management solutions for regulated markets such as the pharmaceutical, medical devices, cosmetics and chemicals industries. By centralising messaging content, Kallik enables large national and international organisations – often with thousands of products – to produce accurate, print-ready artwork for their packaging and labelling in seconds. Kallik stores all content – text, symbols and logos – as structured data, and manage it in a streamlined way. As a result, amending artwork in line with new market-specific requirements is quick and easy – even if multiple product lines are affected, across multiple markets and in multiple languages. For more information visit: http://www.kallik.com/

Press contact
Please feel free to reach out to our PR team via email:

David Callaghan
PR contact
Phone: +44 (0)121 389 2499

Graham Francis
Channel Marketing Manager
Phone: +44 1827 318100
phone +44 (0)1827 318100
email sales@kallik.com
email 2 Anker Court, Bonehill Road, Tamworth, Staffs, B78 3HP
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Phillips-Medisize Enters Agreement with Global Pharmaceutical Company to Acquire Exclusive Ownership of Patents for an Innovative Mini-tablet Dispenser

HUDSON, WI – September 10, 2019 – Phillips-Medisize, a Molex company, announced today an agreement with a Global Pharmaceutical Company, where Phillips-Medisize acquired exclusive ownership of patents supporting an innovative mini-tablet dispenser to accommodate the varied and customized oral dispensing needs of patients.
More info >>


White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement